Fertility and Sterility
Volume 91, Issue 4, Supplement , Pages 1563-1567, April 2009

Long-term consequences of polycystic ovary syndrome on cardiovascular risk

  • Manfredi Rizzo, M.D., Ph.D.

      Affiliations

    • Department of Internal Medicine and Emerging Diseases, University of Palermo, Palermo, Italy
    • Corresponding Author InformationReprint requests: Manfredi Rizzo, M.D., Ph.D., Department of Internal Medicine and Emerging Diseases, University of Palermo, Via del Vespro, 141–90127, Palermo, Italy (FAX: +39-091-6552982).
  • ,
  • Kaspar Berneis, M.D.

      Affiliations

    • Clinics for Endocrinology, Diabetes and Clinical Nutrition, University Hospital, Zurich, Switzerland
  • ,
  • Giatgen Spinas, M.D.

      Affiliations

    • Clinics for Endocrinology, Diabetes and Clinical Nutrition, University Hospital, Zurich, Switzerland
  • ,
  • Giovam Battista Rini, M.D.

      Affiliations

    • Department of Internal Medicine and Emerging Diseases, University of Palermo, Palermo, Italy
  • ,
  • Enrico Carmina, M.D.

      Affiliations

    • Department of Internal Medicine and Emerging Diseases, University of Palermo, Palermo, Italy

Received 19 June 2008; received in revised form 22 September 2008; accepted 23 September 2008. published online 30 October 2008.

Most available data suggest that the prevalence of cardiovascular diseases in women with polycystic ovary syndrome (PCOS) is smaller than expected based on risk calculations during fertile years; therefore, more studies are needed on long-term cardiovascular consequences. Evidence is accumulating that postmenopausal women with PCOS have an increased risk of cerebrovascular events and cardiovascular morbidity. These events are partially related to persisting hyperandrogenism but are mostly correlated with excessive body weight (mainly visceral obesity); this suggests that our best long-term strategy is to ensure that women with PCOS are informed about their high risk for metabolic and cardiovascular diseases.

Key Words: Polycystic ovary syndrome, cardiovascular risk, menopause, events

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 M.R. has nothing to disclose. K.B. has nothing to disclose. G.S. has nothing to disclose. G.B.R. has nothing to disclose. E.C. has nothing to disclose.

PII: S0015-0282(08)04099-5

doi:10.1016/j.fertnstert.2008.09.070

Fertility and Sterility
Volume 91, Issue 4, Supplement , Pages 1563-1567, April 2009